JPH0651624B2 - 骨の損耗の予防又は再生不調症の治療又は予防用薬剤 - Google Patents

骨の損耗の予防又は再生不調症の治療又は予防用薬剤

Info

Publication number
JPH0651624B2
JPH0651624B2 JP1338023A JP33802389A JPH0651624B2 JP H0651624 B2 JPH0651624 B2 JP H0651624B2 JP 1338023 A JP1338023 A JP 1338023A JP 33802389 A JP33802389 A JP 33802389A JP H0651624 B2 JPH0651624 B2 JP H0651624B2
Authority
JP
Japan
Prior art keywords
vitamin
dihydroxy
compound
trans
prevention
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP1338023A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02288829A (ja
Inventor
エフ．デルーカ ヘクター
ケー．シユノーズ ハインシツヒ
アール．シシンスキイ ラファル
洋子 田中
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wisconsin Alumni Research Foundation
Original Assignee
Wisconsin Alumni Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Research Foundation filed Critical Wisconsin Alumni Research Foundation
Publication of JPH02288829A publication Critical patent/JPH02288829A/ja
Publication of JPH0651624B2 publication Critical patent/JPH0651624B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
JP1338023A 1983-05-09 1989-12-26 骨の損耗の予防又は再生不調症の治療又は予防用薬剤 Expired - Lifetime JPH0651624B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09
US492,863 1983-05-09
US60732784A 1984-05-04 1984-05-04
US607,327 1984-05-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP59502223A Division JPS60501261A (ja) 1983-05-09 1984-05-09 １α，２５―ジヒドロキシル化ビタミンＤ↓２化合物及びその製造方法

Publications (2)

Publication Number Publication Date
JPH02288829A JPH02288829A (ja) 1990-11-28
JPH0651624B2 true JPH0651624B2 (ja) 1994-07-06

Family

ID=27050897

Family Applications (3)

Application Number Title Priority Date Filing Date
JP1338023A Expired - Lifetime JPH0651624B2 (ja) 1983-05-09 1989-12-26 骨の損耗の予防又は再生不調症の治療又は予防用薬剤
JP1338024A Granted JPH02288873A (ja) 1983-05-09 1989-12-26 シクロビタミンｄ化合物
JP1338025A Expired - Fee Related JPH0610188B2 (ja) 1983-05-09 1989-12-26 １α，２５―ジヒドロキシル化ビタミンＤ▼下２▲化合物の前駆体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP1338024A Granted JPH02288873A (ja) 1983-05-09 1989-12-26 シクロビタミンｄ化合物
JP1338025A Expired - Fee Related JPH0610188B2 (ja) 1983-05-09 1989-12-26 １α，２５―ジヒドロキシル化ビタミンＤ▼下２▲化合物の前駆体

Country Status (7)

Country Link
JP (3) JPH0651624B2 (da)
AU (1) AU568549B2 (da)
CH (1) CH665834A5 (da)
DE (4) DE3448412C2 (da)
DK (3) DK171397B1 (da)
NL (1) NL193245C (da)
WO (1) WO1984004527A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8520265A (nl) * 1984-10-04 1986-09-01 Wisconsin Alumni Res Found Derivaten van vitamine d en werkwijzen voor het bereiden daarvan.
DE3687377T2 (de) * 1985-01-17 1993-04-29 Wisconsin Alumni Res Found Vitamin-d-abkoemmlinge und deren herstellungsverfahren.
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
JP2645130B2 (ja) * 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
IN171426B (da) * 1990-02-14 1992-10-10 Wisconsin Alumni Res Found
NZ254424A (en) * 1992-06-22 1997-09-22 Lunar Corp Pharmaceutical composition and use of 1 alpha hydroxy-pre-vitamin d
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
NZ336924A (en) 1997-02-13 2001-06-29 Bone Care Int Inc Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
JP5492099B2 (ja) 2008-03-12 2014-05-14 シトクロマ インコーポレイテッド 安定化１，２５−ジヒドロキシビタミンｄ２及びその製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds

Also Published As

Publication number Publication date
DK183291D0 (da) 1991-11-07
DK8685D0 (da) 1985-01-08
DE3490215T (de) 1985-05-15
DK8685A (da) 1985-01-08
NL193245B (nl) 1998-12-01
JPH02288854A (ja) 1990-11-28
DK172567B1 (da) 1999-01-18
DE3448412C2 (da) 1991-12-12
WO1984004527A1 (en) 1984-11-22
JPH02288829A (ja) 1990-11-28
DE3490215C2 (da) 1991-07-25
JPH0339505B2 (da) 1991-06-14
DK184588D0 (da) 1988-04-06
DK171397B1 (da) 1996-10-14
NL8420137A (nl) 1985-04-01
CH665834A5 (de) 1988-06-15
NL193245C (nl) 1999-04-02
DK172733B1 (da) 1999-06-21
DK184588A (da) 1988-04-06
AU568549B2 (en) 1988-01-07
JPH0610188B2 (ja) 1994-02-09
JPH02288873A (ja) 1990-11-28
DK183291A (da) 1991-11-07
DE3448360C2 (da) 1991-10-02
AU3011584A (en) 1984-12-04

Similar Documents

Publication Publication Date Title
US4588716A (en) Method for treating metabolic bone disease in mammals
JP4022141B2 (ja) ２−エチル及び２−エチリデン−１９−ノル−ビタミンｄ化合物
US5552392A (en) Method of treating hypoparathyroidism with (20S) vitamin D compounds
JP4493340B2 (ja) １α−ヒドロキシ−２−メチレン−１９−ノル−プレグナカルシフェロール及びその使用
US7122530B2 (en) 24-hydroxyvitamin D, analogs and uses thereof
JPH09504549A (ja) （ｅ）−２０（２２）−デヒドロビタミンｄ化合物
JPH0651624B2 (ja) 骨の損耗の予防又は再生不調症の治療又は予防用薬剤
EP0578494B1 (en) 24-cyclopropane vitamin D derivatives
WO1997000242A1 (de) Neue vitamin d-derivate mit substituenten an c-25, verfahren zu ihrer herstellung, zwischenprodukte und die verwendung zur herstellung von arzneimitteln
JP2007532540A (ja) ２−アルキリデン１８，１９−ジノル−ビタミンｄ化合物
NL8420327A (nl) Isomeren van hydroxyvitamine d2.
JP2008520716A (ja) ２−メチレン−１８，１９−ジノル−１α−ヒドロキシ−ホモプレグナカルシフェロール及びその使用
US4619920A (en) 26,26,26,27,27-pentafluoro-1α-hydroxy-27-methoxyvitamin D3
JPH0364498B2 (da)
US5552393A (en) Method of treating metabolic bone diseases with 21-norvitamin D compounds
WO1981003023A1 (en) 1 alpha-hydroxy-2 beta-fluorocholecalciferol
US5036061A (en) Process for the preparation of 1 alpha,25-dihydroxylated vitamin D2 and related compounds
DE3590080C2 (da)
JPH0813743B2 (ja) ９，１０−セコプレグナトリエン誘導体を有効成分として含有する医薬